Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Announcement of Resolutions of the 7th Meeting of the 9th Qinghai Spring Board of Directors
Qinghai Spring Notice on Receiving the Shanghai Stock Exchange's “Information Disclosure Regulatory Inquiry Letter on the 2023 Annual Report”
Qinghai Spring Announcement on Abnormal Fluctuations in Stock Trading
Response to the inquiry letter from the controlling shareholder and actual controller of Qinghai Spring
Qinghai Spring Announcement on Abnormal Fluctuations in Stock Trading
Response to the inquiry letter from the controlling shareholder and actual controller of Qinghai Spring
Qinghai Spring Announcement on Abnormal Fluctuations in Stock Trading
Response to the inquiry letter from the controlling shareholder and actual controller of Qinghai Spring
Qinghai Spring Announcement on Abnormal Fluctuations in Stock Trading
Response to the inquiry letter from the controlling shareholder and actual controller of Qinghai Spring
Daxin Certified Public Accountants (Special General Partnership) Special Notice on Issuing a Non-standard Opinion on the Audit of Qinghai Spring's 2023 Financial Statements
Qinghai Spring 2023 Internal Control Audit Report
Qinghai Spring Independent Director Dong Bojun's 2023 Debriefing Report
Qinghai Spring Independent Director Gao Xuemin's 2023 Debriefing Report
Qinghai Spring Independent Director Dong Song Yuqi's 2023 Debriefing Report
Qinghai Spring 2023 Operating Income Deduction Status Special Audit Report
Qinghai Spring Independent Director Dong Li Libing (retired) 2023 Debriefing Report
Announcement of Resolutions of the Fourth Meeting of the 9th Qinghai Spring Supervisory Committee
No Data